Radiotherapy-induced thyroid disorders

Cancer Treatment Reviews

Volumn 30, Issue 4, 2004, Pages 369-384

  Jereczek Fossa, Barbara A ^a   Alterio, Daniela ^a   Jassem, Jacek ^b   Gibelli, Bianca ^a   Tradati, Nicoletta ^a   Orecchia, Roberto ^a,c  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Hyperthyroidism; Hypopituitarism; Hypothyroidism; Injury; Radiation damage; Radiotherapy; Thyroid gland; Thyroiditis; Toxicity

Indexed keywords

AMIFOSTINE; FLUOROURACIL; TAMOXIFEN; THYROID HORMONE; THYROTROPIN; THYROXINE;

AUTOIMMUNE DISEASE; BLOOD VESSEL INJURY; CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL EXAMINATION; ENDOCRINE OPHTHALMOPATHY; GRAVES DISEASE; HEAD AND NECK CANCER; HODGKIN DISEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; NODULAR GOITER; NONHUMAN; PROTON RADIATION; RADIATION DOSE DISTRIBUTION; RADIATION HAZARD; RADIATION INJURY; REVIEW; STEREOTAXIC SURGERY; SUBTOTAL THYROIDECTOMY; THREE DIMENSIONAL IMAGING; THYROID CARCINOMA; THYROID DISEASE; THYROID FUNCTION TEST; THYROID GLAND; THYROIDITIS; WHOLE BODY RADIATION;

EID: 2942622484     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2003.12.003     Document Type: Article

References (149)

1. Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 1995;31:1165-70.
2. Utiger RD. Control of thyroid hormone synthesis. In: Kelly WN, editor. Textbook of internal medicine. Philadelphia: JB Lippincott; 1989. p. 2115-9.
3. Cannon CR. Hypothyroidism in head and neck cancer patients: experimental and clinical observations. Laryngoscope 1994;104:1-21.
4. Blumgart HI, Freedborg AS, Kurlnad GS. Treatment of incapacitated euthyroid cardiac patients with radioactive iodine. JAMA 1955;157:1-4.
5. Jaffe JL, Rosenfeld MH, Pobirs FW, et al. Radioiodine treatment of euthyroid cardiac disease. JAMA 1955;159: 434.
6. Einhorn J, Wilkholm MG. Hypothyroidism after external irradiation of the thyroid region. Radiology 1967;88: 326-8.
7. Felix H, Dupre N, Drape M, Court L. Incidence à long terme d'une radiotherapie pour cancer du larynx, sur l'aparition d'un myxoedeme. Lyon Med 1961;93:1043-50.
8. Markson JL, Flatman GE. Myxedema after deep X-ray therapy to the neck. South Med J 1965;1:1228-30.
9. Sinard RJ, Tobin EJ, Mazzaferri EL, Hodgson SE, et al. Hypothyroidism after treatment for nonthyroid head and neck cancer. Arch Otolaryngol Head Neck Surg 2000;126:652-7.
10. Turner SL, Tiver KW, Boyages SC. Thyroid dysfunction following radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 1994;31:279-83.
11. Colevas AD, Read R, Thornhill J, et al. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 2001;51:599-604.
12. Zohar Y, Tovim RB, Laurian N, Laurian L. Thyroid function following radiation and surgical therapy in head and neck malignancy. Head Neck Surg 1984;6:948-52.
13. Thorp MA, Levitt NS, Mortimore S, Isaacs S. Parathyroid and thyroid function five years after treatment of laryngeal and hypopharyngeal carcinoma. Clin Otolaryngol 1999;24: 104-8.
14. Vrabec DP, Heffron TJ. Hypothyroidism following treatment for head and neck cancer. Ann Otol Rhinol Laryngol 1981;90:449-53.
15. Weissler MC, Berry BW. Thyroid stimulating hormone levels after radiotherapy and combined therapy for head and neck cancer. Head Neck 1991;13:420-3.
16. Bethge W, Guggenberger D, Bamberg M, Kanz L, Bokemeyer C. Thyroid toxicity of treatment for Hodgkin's disease. Ann Hematol 2000;79:114-8.
17. Kumpulainen EJ, Hirvikoski PP, Viraniemi JA, et al. Hypothyroidism after radiotherapy for laryngeal cancer. Radiother Oncol 2000;57:97-101.
18. Liao Z, Ha CS, Vlachaki MT, et al. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure. Int J Radiat Oncol Biol Phys 2001;50:971-7.
19. Posner MR, Ervin TJ, Fabian RL, et al. Incidence of hypothyroidism following multimodality treatment for advanced squamous call cancer of the head and neck. Laryngoscope 1984;94:451-4.
20. Shafer RB, Nuttall FQ, Pollack K, Kuisk H. Thyroid function after radiation and surgery for head and neck cancer. Arch Int Med 1975;135:843-6.
21. Smolarz K, Malke G, Voth E, et al. Hypothyroidism after therapy for larynx and pharynx carcinoma. Thyroid 2000;10:425-9.
22. Constine LS. What else don't we know about the late effects of radiation in patients treated for head and neck cancer? Int J Rodiat Oncol Biol Phys 1994;31:427-9.
23. Mercado G, Adelstein DJ, Saxton JP, Secic M, Larto MA, Lavertu P. Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer 2001;92:2892-7.
24. Constine LS, Donaldson SS, MCDougall IR. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer 1984;53:878-83.
25. Illes A, Biro E, Miltenyi Z, et al. Hypothyroidism and thyroiditis after therapy for Hodgkin's disease. Acta Haematol 2003;109:11-7.
26. Murtha AD, Knox SJ, Hoppe RT, Rupnow BA, Hanson J. Longterm follow-up of patients with stage III follicular lymphoma treated with primary radiotherapy at Stanford University. Int J Radiat Oncol Biol Phys 2001;49:3-15.
27. Paulino AC. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 2002;53:5437.
28. Thomas O, MahéMA, Campion L, et al. Long-term comptications of total body irradiation in adults. int J Radiat Oncol Biol Phys 2001;49:125-31.
29. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
30. Cutuli Quentin P, Rodier J-F, Barakat P, Grob J-C. Severe hypothyroidism after chemotherapy and locoregional irradiation for breast cancer. Radiother Oncol 2000;57:103-5.
31. Nishiyama K, Kozuka T, Higashihara T, Miyauchi K, Okagawa K. Acute radiation thyroiditis. Int J Radiat Oncol Biol Phys 1996;36:1221-4.
32. Nishiyama K, Tanaka E, Tarui Y, Miyauchi K, Okagawa K. A prospective analysis of subacute thyroid dysfunction after neck irradiation. Int J Radiat Oncol Biol Phys 1996;34: 439-44.
33. DeGroot LJ. Clinical review 2: diagnostic approach and management of patients exposed to irradiation to the thyroid. J Clin Endocrinol Metabol 1989;69:925-8.
34. Ricardi U, Corrias A, Einaudi S, et al. Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 2001;50:1287-94.
35. Roman SA. Endocrine tumours: evaluation of the thyroid nodule. Curr Opin Oncol 2003; 15:66-70.
36. Acharya S, Sarafoglou K, LaQuaglia M, et al. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 2003;97: 2397-403.
37. Inskip PD. Thyroid cancer after radiotherapy for childhood cancer. Med Ped Oncol 2001;36:568-73.
38. Hull MC, Mendenhall NP, Morris CG. Second malignancies in patients treated with radiation therapy for Hodgkin's lymphoma (Abstr. 242). Int J Radiat Oncol Biol Phys 2002; 54(Suppl):142-3.
39. Tucker MA, Jones PH, Boice JD, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 1991;51:2885-8.
40. Ron E. Ionizing radiation and cancer risk: evidence from epidemiology. Radiat Res 1998;150:S30-41.
41. Somerville HM, Steinbeck KS, Stevens G, Delbridge LW, Lam AH, Stevens MM. Thyroid neoptasia following irradiation in adolescent and young adults survivors of childhood cancer. Med J Aust 2002; 176:584-7.
42. Eckert CT, Probstein JG, Galison S. Radiation of the thyroid: an experimental study in radiosensitivity of the thyroid. Radiology 1937;29:40-4.
43. Feehs RS, McQuirt WT, Bond MG. Irradiation: a significant factor for carotid atherosclerosis. Arch Otolaryngol Head Neck Surg 1991;117:1135-7.
44. Rubin P, Cassarett GW. The endocrine glands in clinical radiation pathology. Philadephlia: WB Saunders; 1968. p. 749-64.
45. DeGroot LJ. Radiation and thyroid disease. Bailliere Clin Endocrinol Metabol 1988;2:777-91.
46. Dejong JMA, VonDoal WAJ, Elte JWF, et al. Primary hypothyroidism as a complication after treatment of tumours of the head and neck. Acta Radiol (Oncol) 1982; 21:299-303.
47. Biel MA, Maisel RH. Indications for performing hemithyroidectomy for tumours requiring total laryngectomy. Arch Otolaryngol Head Neck Surg 1985;150:43 5-9.
48. Tami TA, Gomez P, Parker GS, Gupta MB, Frassica DA. Thyroid dysfunction after radiation therapy in head and neck cancer patients. Am J Otolaryngol 1992;13:357-62.
49. Liening DA, Duncan NO, Blakeslee DB, Smith DB. Hypothyroidism following radiotherapy for head and neck cancer. Laryngol Head Neck Surg 1990;103:10-3.
50. Leon X, Gras JR, Perez A, et al. Hypothyroidism in patients treated with total laryngectomy. A multivariate study. Eur Arch Otorhinolaryngol 2002;259:193-6.
51. Carr RF, Livolsi VA. Morphologic changes in the thyroid after irradiation for Hodgkin's and non Hodgkin's lymphoma. Cancer 1989;64:825-9.
52. Fajardo LF. Pathology of radiation injury. NY: Masson; 1982. p. 205-12.
53. Perez CA, Brady LW. Quantification of treatment toxicity. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 2nd ed. Philadelphia: JB Lippincott; 1992. p. 51-5.
54. LENT SOMA Tables. Radiother Oncol 1995;35:17-60.
55. Green DM, Brecken ML, Yakar D, et al. Thyroid function in paediatric patients after neck irradiation for Hodgkin's disease. Med Ped Oncol 1980;8:127-36.
56. Palmer BB, Gaggar N, Shaw HJ. Thyroid function after radiotherapy and laryngectomy for carcinoma of the larynx. Head Neck Surg 1981;4:13-5.
57. Lam KSL, Tse VKC, Wang C, Yeung RT, Ho JH. Effects of cranial irradiation on hypothalamic-pituitary function - a 5-year longitudinal study in patients with nasopharyngeal carcinoma. Q J Med 1991;78:165-76.
58. Leung T-W, Tung SY, Sze W-K, Sze W-M, Wong VY, O S-K. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000;47:405-12.
59. Nelson Df, Reddy KV, O'Mara RE, et al. Thyroid abnormalities following neck irradiation of Hodgkin's disease. Cancer 1978;42:2553-612.
60. Kim YH, Fayos JV, Sisson JC. Thyroid function following neck irradiation for malignant lymphoma. Radiology 1980; 134:205-8.
61. Farley PC. Thyroid dysfunction following radiation therapy for lymphoma in the military population. Mil Med 1983;148:740-2.
62. Dobbs JH. Thyroid damage after treatment of Hodgkin's disease. Clin Oncol 1983;9:51-6.
63. Shafford EA, Kingston JE, Healy JC, Webb JA, Plowman PN, Rezne RH. Thyroid nodular disease after radiotherapy to the neck for childhood Hodgkin's disease. Br J Cancer 1999;80:808-14.
64. Ding SH, Pledge SD, Harrison BJ, et al. The incidence of thyroid abnormalities in adults irradiated for lymphoma. Int J Oncol 2002;20:1065-9.
65. Glatstein E, McHardy-Young S, Brast N, Eltringham JR, Kriss JP. Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol Metabol 1971;32:833-44.
66. Tamura K, Shimaoka K, Friedman M. Thyroid abnormalities associated with treatment of malignant lymphoma. Cancer 1981;47:2704-11.
67. Knobel H, Loge JH, Lund MB, Forfang K, Nome O, Kaasa S. Late medical complications and fatigue in Hodgkin's disease survivors. J Clin Oncol 2001;19:3226-33.
68. Petersen M, Keeling CA, McDougall IR. Hyperthyroidism with low radioiodine uptake after head and neck irradiation for Hodgkin's disease. J Nucl Med 1989;30:255-7.
69. Ruhl U, Albrecht M, Dieckmann K, et al. Response-adapted radiotherapy in the treatment of paediatric Hodgkin's disease: an interim report at 5 years of the German GPOH-HD 95 trial. Int J Radiat Oncol Biol Phys 2001;51:1209-18.
70. Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Uttley D. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol 1993;38:571.
71. Constine LS, Woolf PD, Cann D, et al. Hypothalamic -pituitary dysfunction after radiation for brain tumours. N Engl J Med 1993;328:87-94.
72. Constine LS, Rubin P, Woolf PD, Doane K, Lush C. Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies. J Clin Oncol 1987;5:1841-51.
73. Ogilvy-Stuart AL, Shalet SM, Gattamameni HR. Thyroid function after treatment of brain tumours in children. J Pediatr 1991; 119:733-7.
74. Merchant TE, Sherwood SH, Mulhern RK, et al. CNS germinoma: disease control and long-term functional outcome for 12 children treated with craniospinal irradiation. Int J Radiat Oncol Biol Phys 2000;46:1171-6.
75. Kitamura K, Shirato H, Sawamura Y, et al. Preirradiation evaluation and technical assessment of involved-field radiotherapy using computed tomographic (CT) simulation and neoadjuvant chemotherapy for intracranial germinoma. Int J Radiat Oncol Biol Phys 1999;43:783-8.
76. Saki N, Tamaki K, Murai H, et al. Long-term outcome of endocrine function in patients with neurohypophyseal germinomas. Endocr J 2000;47:83-9.
77. Fisch BM, Mar C, Sneed PK, Larson DA, Wilson CB, Wara WM. Radiation therapy for craniopharyngiomas: the UCSF experience (Abstr. 1025). Int J Radiat Oncol Biol 2002;48(Suppt):259-60.
78. Merchant TE, Kiehna EN, Sanford RA, et al. Craniopharyngioma: The St. Jude Children's Research Hospital Experience 1984-2001. Int J Radiat Oncol Biol Phys 2002;53:533-42.
79. Habrand J-L, Ganry O, Couanet D, et al. The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys 1999;44:255-63.
80. Coen JJ, Yock B, Swearingen B, et al. Stereotactic proton radiosurgery in the management of persistent acromegaly (Abstr. 289). Int J Radiat Oncol Biol Phys 2001;51(Suppl):161-2.
81. Yock TI, Coen JJ;, Swearingen B, et al. Stereotactic proton beam radiosurgery for ACTH producing adenomas in the MRI/CT era (Abstr. 290). Int J Radiat Oncol Biol Phys 2001;51 (Suppl): 162.
82. Schultz-Ertner D, Frank C, Herfarth KK, Rhein B, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy for craniopharyngioma. Int J Radiat Oncol Biol Phys 2002; 54:1114-20.
83. Zissiadis Y, Dutton S, Kieran M, et al. Stereotactic radiotherapy for paediatric intracranial germ cell tumours. Int J Radiat Oncol Biol Phys 2001;51:108-12.
84. Johannesen TB, Hole KH, Rasmussen K, et al. Late radiation injury of the central nervous system, recording of morbidity according to the SOMA/LENT scoring system (Abstr. 2051). Int J Radiat Oncol Biol Phys 2001;51(Suppl):251-2.
85. Oberfield SE;, Allen JC, Pollack J, New MF, Levine LS. Longterm endocrine sequelae after treatment of medullobtastoma: prospective study of growth and thyroid function. J Pediatr 1986;108:219-23.
86. Schmiegelow M, Feldt-Rasmussen U, Rasmussen U, Poulsen HS, Muller J. A population-based study of thyroid function after radiotehrapy and chemotherapy for a childhood brain tumour. J Clin Endocrinol Metabol 2003;88:136-40.
87. Rose SR, Lustig RH, Pitukcheewanont P, et al. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metabol 1999;84:4472-9.
88. Heikens J, Michiels EM, Behrendt H, Endert E, Bakker PJ, Fliers E. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma. Eur J Cancer 1998; 34:1592-7.
89. Paulino AC, Narayana A, Mohideen MN, Jeswani S. Posterior fossa boost in medulloblastoma: An analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy. Int J Radiat Oncol Biol Phys 2000;46:281-6.
90. Tarbell NJ, Smith AR, Adams J, Loeffler JS. The challenge of conformal radiotherapy in the curative treatment of medulloblastoma. Int J Radiat Oncol Biol Phys 2000;46: 265-6 [editorial].
91. Narayana A, Jeswani S, Pautino AC. The cranio-spinal junction in medulloblastoma: does it matter? Int J Radiat Oncol Biol Phys 1999;44:81-4.
92. Merchant TE, Williams T, Smith JM, et al. Preirradiation endocrinopathies in paediatric brain tumour patients determined by dynamic tests of endocrine function. Int J Radiat Oncol Biol Phys 2002;54:45-50.
93. Hata M, Ogino I, Aida N, et al. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: Outcomes of late effects on pituitary function and growth in long-term survivors. Int J Cancer 2001;96(Suppl): 117-24.
94. Lando A, Holm K, Nysom K, et al. Thyroid function in survivors of childhood acute lymphobtastic leukaemia: the significance of prophylactic cranial irradiation. Clin Endocrinol 2001;55:21-5.
95. Stevens G, Downes S, Ralston A. Thyroid dose in children undergoing prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1998;42:385-90.
96. Paulino AC, Simon JH, Zhen W, Wen B-C. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2000;48:489-1495.
97. Ogilvy-Stuart AL, Clark DJ, Wallace WH, et al. Endocrine deficits after fractionated total body irradiation. Arch Dis Child 1992;67:1107-10.
98. Sklar CA, Kim TH, Ramsay NKC. Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med 1982;73:688-94.
99. Ricardi U, Vassallo E, Miniero, R, Filippi AR, Fagioli F, Rossi G. Long-term complications of total body irradiation in children affected with acute lymphobtastic leukemia (Abstr. 213). Int J Radiat Oncol Biol Phys 2001;51 (Suppl): 119-20.
100. Bakker B, Massa GG, van Rijn AM, et al. Effects of total-body irradiation on growth, thyroid and pituitary gland in rhesus monkeys. Radiother Oncol 1999;51:187-92.
101. Pai HH, Thornton A, Katznelson L, et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2001;49:1079-92.
102. Bruning P, Bonfrer J, De Jong-Bakker M, Nooyen W, Burgers M. Primary hypothyroidism in breast cancer patients with irradiated supraclavicular lymph nodes. Br J Cancer 1985;51:659-63.
103. Joensuu H, Vlikari J. Thyroid function after postoperative radiation therapy in patients with breast cancer. Acta Radial Oncol 1986;25:167-70.
104. Beyssen ML, Lagorce JF, Cledat D, Jambut AC, Buxeraud J. Antithyroid action of tamoxifen in the rat - in vivo and in vitro studies. Pharmacology 2000;61:22-30.
105. Kostoglou-Athanassiou I, Ntalles K, Markopoulos C, Athanassiou P, Gogas J, Proukakis C. Thyroid function in postmenopausal women with breast cancer on tamoxifen. Eur J Gynecol Oncol 1998; 19:150-4.
106. Zidan J, Rubenstein W. Effect of adjuvant tamoxifen therapy on thyroid function in postmenopausal women with breast cancer. Oncology 1999;56:43-5.
107. Huang J, Walker R, Groome PG, Shelley W, Mackillop WJ. Risk of thyroid carcinoma in a female population after radiotherapy for breast cancer. Cancer 2001;92:1411-8.
108. Jakob A, Kollmannsberger C, Kanz L, Bokemeyer C. Late toxicity after chemotherapy of malignant testicular tumours. Urologe A 1998;37:635-47 [in German].
109. Schafer DW, Lubin JH, Ron E, Stovall M, Carroll RJ. Thyroid cancer following scalp irradiation: a reanalysis accounting for uncertainty in dosimetry. Biometrics 2001;57: 689-97.
110. Mihailescu D, Shore-Freedman E, Mukani S, Lubin J, Ron E, Schneider AB. Multiple neoplasms in an irradiated cohort: pattern of occurrence and relationship to thyroid cancer outcome. J Clin Endocrinol Metabol 2002;87:3236-41.
111. Damber L, Johansson L, Johansson R, Larsson LG. Thyroid cancer after X-ray treatment of benign disorders of the cervical spine in adults. Acta Oncol 2002;41:25-8.
112. Ronckers CM, Van Leeuwen FE, Hayes RB, Verduijn PG, Stovall M, Land CE. Cancer incidence after nasopharyngeal radium irradiation. Epidemiology 2002; 13:552-60.
113. Yeh H, Matanoski GM, Wang NY, Sandler DP, Comstock GW. Cancer incidence after childhood nasopharyngeal radium irradiation: a follow-up study in Washington County. Am J Epidemiol 2001; 153:749-56.
114. Broerse JJ, Jansen JT, Zoetetief J, Seegenschmiedt MH. Assessment of carcinogenic risk in radiotherapy for nonmalignant diseases (Abstr. 2159). Int J Radiat Oncol Biol Phys 2002;54(Suppl):302.
115. Broerse JJ, Snijders-Keiholz A, Jansen JTM, et al. Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry. Radiother Oncol 1999;53:205-8.
116. Micke O, Seegenschmiedt MH, German Working Group on Radiotherapy of Benign Diseases. Consensus guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys 2002;52:496-513.
117. Akmansu M, Dirican B, Bora H, Gurel O. The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves' orbitopathy. Ophthalm Res 2003;35: 150-3.
118. Littley MD, Shalet SM, Beardwell GG, Robinson EL, Sutton MD. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol 1989;31:363-73.
119. Regine WC, Mohiuddin M, Kramer S. Long-term results of paediatric and adult craniopharyngioma treated with combined surgery and radiation. Radiother Oncol 1993; 27:13-21.
120. Kaplan MM, Garnick MB, Gelber R, et al. Risk factors for thyroid abnormalities after neck irradiation for childhood cancer. Am J Med 1983;74:272-80.
121. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to the therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
122. Shakespeare TP, Dwyer M, Mukherjee R, Yeghiaian-Alvandi R, Gebski V. Estimating risk of radiotherapy complications as part of informed consent: the high degree of variability between radiation oncologists may be related to experience. Int J Radiat Oncol Biol Phys 2002;54:647-53.
123. Yoden E, Maruta T, Soejima T, et al. Hypothyroidism after radiotherapy to the neck (Abstr. 2216). Int J Radiat Oncol Biol Phys 2001;51(Suppl):337-8.
124. Marcial-Vega VA, Order SE;, Lastner G, Cole PD, LaFrance N, O'Neill M. Prevention of hypothyroidism related to mantle irradiation for Hodgkin's disease: preparative phantom study. Int J Radiat Oncol Biol Phys 1990; 18:613-8.
125. Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiation-induced second cancer by using proton beams in the treatment of paediatric tumours. Int J Radiat Oncol Biol Phys 2002;54:824-9.
126. Halt EJ, Wuu C-S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56:83-8.
127. Soberman N, Leonidas JC, Cherrick I, Schiff R, Karayalcin G. Sonographic abnormalities of the thyroid gland in long term survivors of Hodgkin's disease. Pediatr Radiol 1991;21:250-3.
128. Stewart RR, David CL, Eftekhari F, Ried HL, Fuller LM, Fornage BD. Thyroid gland: US in patients with Hodgkin's disease treated with radiation therapy in childhood. Radiology 1989;172:159.
129. Sandhu A, Constine LS, O'Mara RE, Hinkle A, Muhs AG, Woolf PD. Subclinical thyroid disease after radiation therapy detected by radionuclide scanning. Int J Radiat Oncol Biol Phys 2000;48:181-8.
130. Burch HB. Evaluation and management of the solid thyroid nodule. Endocrinol Metabol Clin North Am 1995;24: 663-710.
131. Marx M, Beck JD, Muller H, Kuhl J, Langer T, Dorr HG. Late hormonal complications after brain tumour treatment in childhood and adolescence: literature review and a model of integrated hormone aftercare. Klin Pediatr 2000;212: 224-8 [in German].
132. Dayan CM. Interpretation of thyroid function tests. Lancet 2001;357:619-24.
133. Bantle JP, Lee CKK, Levitt SH. Thyroxine administration during radiation therapy to the neck does not prevent subsequent thyroid dysfunction. Int J Radiat Oncol Biol Phys 1985;11:1999-2002.
134. Zoberi I, Wasserman TH, Chao KS. A prospective, nonrandomized study of the impact of amifostine on subsequent hypothyroidism in irradiated patients with head and neck cancer. Semin Radiat Oncol 2002;12(Suppl):14-7.
135. Smeester P, Fruhling J, Van Bladel L, Wambersie A. Nuclear accidents and iodine prophylaxis. Part I: Risks due to irradiation of the thyroid gland. Rev Med Bruxelles 1998;19:475-82 [in French].
136. Schlumberger KM. Thyroid cases after Chernobyl: importance of prophylaxis. Radioprotection 1994;29:397-404.
137. Kuten A, Lubochitski R, Fishman G, Date J, Stein M. Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy. J Surg Oncol 1996;61:281-3.
138. Schneider AB, Recant W, Pinsky SM, Ryo UY, Beckerman C, Shore-Freedman E. Radiation-induced thyroid carcinoma: clinical course and results of therapy in 296 patients. Ann Int Med 1986; 105:405-12.
139. Atahan IL, Yildiz F, Ozyar E, Uzal D. Thyroid dysfunction in children receiving neck irradiation for Hodgkin's disease. Radiat Med 1998; 16:359-61.
140. Paris KJ, Guan T, Pagliuca T, et al. Electron beam vs. photon beam coverage of the spinal axis in paediatric patients with primary CNS malignancies. Int J Radiat Oncol Biol Phys 1996;36(Suppl):365.
141. Gaspar LED, Dawson DJ, Tilley-Gulliford SA, et al. Medullobtastoma: tong-term follow-up of patients treated with electron irradiation of the spinal field. Radiology 1991; 180:867-80.
142. Chin D, Sklar C, Donahue B, et al. Thyroid dysfunction as a late effect in survivors of paediatric medullotobtastoma/primitive neuroectodermal tumours: a comparison of hyperfractionated versus conventional radiotherapy. Cancer 1977;80:798-804.
143. Teo PML, Leung SF, et al. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurological complication. Int J Radiat Oncol Biol Phys 2000;48:1311-22.
144. Livesey EA, Brook CGD. Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child 1989;64:593-5.
145. Posner MR, Weichselbaum RR, Fitzgerald TJ, et al. Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1985;11:1887-93.
146. Smith RE, Adlen RA, Clark P, et al. Thyroid function after mantle irradiation in Hodgkin's disease. JAMA 1981;245: 46-9.
147. Green S, Weiss GR. Southwest Oncology Group standard response criteria, endopoint definitions and toxicity criteria. Invest New Drugs 1992;10:239-53.
148. Tell R, Sjodin H, Lundell G, Lewin F, Lewensohn R. Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 1997;39:303-8.
149. Grande C. Hypothyroidism following radiotherapy for head and neck cancer: multivariate analysis of risk factors. Radiother Oncol 1992;25:31-6.